PLIANT THERAPEUTICS, INC. Other Noncash Income (Expense)
PLIANT THERAPEUTICS, INC. (PLRX) reported Other Noncash Income (Expense) of $264.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2022-11-08
- 2022-09-30: Other Noncash Income (Expense) 9 month $264.00K.
- 2021-09-30: Other Noncash Income (Expense) 9 month -$914.00K.
| Period end | Other Noncash Income (Expense) 9 month |
|---|---|
| 2022-09-30 | $264.00K 10-Q · filed 2022-11-08 |
| 2021-09-30 | -$914.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |